000 01809nam  2200361zi 4500
0019.918049
003CaOODSP
00520230314135032
006m     o  d f      
007cr mn|||||||||
008221206e202302##oncd    ob   f000 0 eng d
020 |a9780660466118
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP40-327/2023E-PDF
24500|aNational report : |bfindings from the Survey on the Impact of COVID19 on access to STBBI-related services, including harm reduction services for people who use drugs or alcohol in Canada.
264 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cFebruary 2023.
264 4|c©2023
300 |a1 online resource (35 pages) : |bcharts
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Rapport national : résultats de l'Enquête sur l'incidence de la COVID-19 sur l'accès aux services de santé liés aux ITSS, y compris les services de réduction des méfaits chez les personnes qui consomment des drogues ou de l'alcool au Canada.
504 |aIncludes bibliographical references (pages 32-34).
650 0|aCOVID-19 Pandemic, 2020-|xHealth aspects|zCanada.
650 0|aSexually transmitted diseases|zCanada|xPrevention.
650 0|aSexually transmitted diseases|xTreatment|zCanada.
650 0|aBloodborne infections|zCanada|xPrevention.
650 0|aBloodborne infections|xTreatment|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
77508|tRapport national : |w(CaOODSP)9.918054
85640|qPDF|s1.66 MB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/HP40-327-2023-eng.pdf